Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells

Thrombosis and Haemostasis

Volumn 97, Issue 5, 2007, Pages 822-829

  Jensen, Torstein ^a   Kierulf, Peter ^a   Sandset, Per M ^a   Klingenberg, Olav ^b   Joø, Gunn B ^a   Godal, Hans C ^a   Skjønsberg, Ole H ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cytokines; Fibrin; Fibrinogen; Inflammation; PMBC

Indexed keywords

AMMONIUM SULFATE; CYTOKINE; FIBRIN; FIBRINOGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ISOLATION; CELL LYSATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRECIPITATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN STRUCTURE; REAL TIME POLYMERASE CHAIN REACTION;

EID: 34249049193     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-01-0039     Document Type: Article

References (41)

1. Holm B, Godal HC. Quantitation of the three normally-occurring plasma fibrinogens in health and during so-called "acute phase" by SDS electrophoresis of fibrin obtained from EDTA-plasma. Thromb Res 1984; 35: 279-290.
2. Drury D, McMaster P. The liver as the source of fibrinogen. J Exp Med 1929; 50: 569-678.
3. Lipinska I, Lipinski B, Gurewich V, et al. Fibrinogen heterogeneity in cancer, in occlusive vascular disease, and after surgical procedures. Am J Clin Pathol 1976; 66: 958-966.
4. Stone MC, Thorp JM. Plasma fibrinogen - a major coronary risk factor. J R Coll Gen Pract 1985; 35: 565-569.
5. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984 23; 311: 501-505.
6. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1991; 338: 1079.
7. Hoff HF, Heideman CL, Jackson RL, et al. Localization patterns of plasma apolipoproteins in human atherosclerotic lesions. Circ Res 1975; 37: 72-79.
8. Sadoshima S, Tanaka K. Fibrinogen and low density lipoprotein in the development of cerebral atherosclerosis. Atherosclerosis 1979; 34: 93-103.
9. Woolf N, Crawford T. Fatty streaks in the aortic intima studied by an immuno-histochemical technique. J Pathol Bacteriol 1960; 80: 405-408.
10. Perez RL, Roman J. Fibrin enhances the expression of IL-1 beta by human peripheral blood mononuclear cells. Implications in pulmonary inflammation. J Immunol 1995; 154: 1879-1887.
11. Perez RL, Ritzenthaler JD, Roman J. Transcriptional regulation of the interleukin-1beta promoter via fibrinogen engagement of the CD18 integrin receptor. Am J Respir Cell Mol Biol 1999; 20: 1059-1066.
12. Dinarello CA. Proinflammatory cytokines. Chest 2000; 118: 503-508.
13. Altieri DC, Plescia J, Plow EF. The structural motif glycine 190-valine 202 of the fibrinogen gamma chain interacts with CD11b/CD18 integrin (alpha M beta 2, Mac-1) and promotes leukocyte adhesion. J Biol Chem 1993; 268: 1847-1853.
14. Ugarova TP, Yakubenko VP. Recognition of fibrinogen by leukocyte integrins. Ann NY Acad Sci 2001; 936: 368-385.
15. Graves KL, Roman J. Fibronectin modulates expression of interleukin-1 beta and its receptor antagonist in human mononuclear cells. Am J Physiol 1996; 271: L61-L69.
16. Leroyer C, Escoffre M, Le Moigne E, et al. Diagnostic value of a new sensitive membrane based technique for instantaneous D-dimer evaluation in patients with clinically suspected deep venous thrombosis. Thromb Haemost 1997; 77: 637-40.
17. Jensen T, Halvorsen S, Godal HC, et al. The viscosity of fibrinogen subfractions and of EDTA denatured fibrinogen do not differ from that of native fibrinogen. Thromb Res 2004; 113: 51-56.
18. Weinstein MJ, Deykin D. Quantitative abnormality of an Aalpha chain molecular weight form in tke fibrinogen of cirrhotic patients. Br J Haematol 1978; 40: 617-630.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
20. Jensen T, Halvorsen S, Godal HC, et al. Discrepancy between fibrinogen concentrations determined by clotting rate and clottability assays during the acute-phase reaction. Thromb Res 2000; 100: 397-403.
21. De Groote D, Zangerle PF, Gevaert Y, et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992; 4: 239-248.
22. Oliver JC, Bland LA, Oettinger CW, et al. Cytokine kinetics in an in vitro whole blood model following an endotoxin challenge. Lymphokine Cytokine Res 1993; 12: 115-20.
23. Sitrin RG, Pan PM, Srikanth S, et al. Fibrinogen activates NF-kappa B transcription factors in mono-nuclear phagocytes. J Immunol 1998; 161: 1462-1470.
24. Altieri DC. Occupancy of CD11b/CD18 (Mac-1) divalent ion binding site(s) induces leukocyte adhesion. J Immunol 1991; 147: 1891-1898.
25. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328: 1471-1477.
26. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996; 12: 697-715.
27. Dvorak HF, Senger DR, Dvorak AM, et al. Regulation of extravascular coagulation by microvascular permeability. Science 1985; 227: 1059-1061.
28. Clark RA, Lanigan JM, DellaPelle P, et al. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 1982; 79: 264-269.
29. Fan ST, Edgington TS. Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response. J Clin Invest 1991; 87: 50-57.
30. Fan ST, Edgington TS. Integrin regulation of leukocyte inflammatory functions. CD11b/CD18 enhancement of the tumor necrosis factor-alpha responses of monocytes. J Immunol 1993; 150: 2972-2980.
31. Pakianathan DR. Extracellular matrix proteins and leukocyte function. J Leukoc Biol 1995; 57: 699-702.
32. Trezzini C, Schuepp B, Maly FE, et al. Evidence that exposure to fibrinogen or to antibodies directed against Mac-1 (CD11b/CD18; CR3) modulates human monocyte effector functions. Br J Haematol 1991; 77: 16-24.
33. Kang YH, Lee CH, Monroy RL, et al. Uptake, distribution and fate of bacterial lipopolysaccharides in monocytes and macrophages: an ultrastructural and functional correlation. Electron Microscopy Rev 1992; 5: 381-419.
34. Lin WJ, Yeh WC. Implication of Toll-like receptor and tumor necrosis factor alpha signaling in septic shock. Shock 2005; 24: 206-209.
35. Maris NA, de Vos AF, Bresser P, et al. Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers. Thromb Haemost 2005; 93: 1036-40.
36. Pan SL, Guh JH, Peng CY, et al. A potential role of YC-1 on the inhibition of cytokine release in peripheral blood mononuclear leukocytes and endotoxemic mouse models. Thromb Haemost 2005; 93: 940-948.
37. Wu KH, Wu WM, Lu MY, et al. Inhibitory effect of pooled human immunoglobulin on cytokine production in peripheral blood mononuclear cells. Pediatr Allergy Immunol 2006; 17: 60-68.
38. Roman J, Ritzenthaler JD, Perez RL, et al. Differential modes of regulation of interleukin-1beta expression by extracellular matrices. Immunology 1999; 98: 228-237.
39. Tang L, Eaton JW. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med 1993; 178:2147-2156.
40. Tang L, Ugarova TP, Plow EF, et al. Molecular determinants of acute inflammatory responses to biomaterials. J Clin Invest 1996; 97: 1329-1334.
41. Busso N, Peclat V, Van Ness K, et al. Exacerbation of antigen-induced arthritis in urokinase-deficient mice. J Clin Invest 1998; 102: 41-50.